The MarketWatch News Department was not involved in the creation of this content. Pipeline of Disease-Modifying Therapies Targets Hypoparathyroidism, Pancreatic Cancer, osteoporotic fractures, and ...
NES ZIONA, Israel, Nov. 24, 2025 /PRNewswire/ -- Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, today announced that the first patient has been ...
NES ZIONA, Israel, Sept. 2, 2025 /PRNewswire/ -- Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, announced today the appointment of Eden Ben as its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback